Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Probi is a leading Swedish biotechnology company focused on the research, development, and manufacture of clinically documented probiotics. The company specializes in identifying and validating specific probiotic strains, most notably Lactobacillus plantarum 299v, to improve human health across various therapeutic areas including gastrointestinal health, immune function, and nutrient absorption. Probi operates a B2B business model, providing high-quality probiotic ingredients and finished formats to global pharmaceutical, food, and dietary supplement companies. With a robust portfolio of over 400 patents and a strong emphasis on clinical evidence, Probi is a key player in the global microbiome and nutraceutical markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on probiotics.